Look Up > Drugs > Paromomycin
Paromomycin
Pronunciation
U.S. Brand Names
Generic Available
Synonyms
Pharmacological Index
Use
Pregnancy Risk Factor
Contraindications
Warnings/Precautions
Adverse Reactions
Overdosage/Toxicology
Drug Interactions
Mechanism of Action
Pharmacodynamics/Kinetics
Usual Dosage
Dietary Considerations
Mental Health: Effects on Mental Status
Mental Health: Effects on Psychiatric Treatment
Dental Health: Local Anesthetic/Vasoconstrictor Precautions
Dental Health: Effects on Dental Treatment
Patient Information
Nursing Implications
Dosage Forms
References

Pronunciation
(par oh moe MYE sin)

U.S. Brand Names
Humatin®

Generic Available

No


Synonyms
Paromomycin Sulfate

Pharmacological Index

Amebicide


Use

Treatment of acute and chronic intestinal amebiasis; preoperatively to suppress intestinal flora; tapeworm infestations; treatment of Cryptosporidium


Pregnancy Risk Factor

C


Contraindications

Intestinal obstruction, renal failure, known hypersensitivity to paromomycin or components


Warnings/Precautions

Use with caution in patients with impaired renal function or possible or proven ulcerative bowel lesions


Adverse Reactions

1% to 10%: Gastrointestinal: Diarrhea, abdominal cramps, nausea, vomiting, heartburn

<1%: Headache, vertigo, exanthema, rash, pruritus, steatorrhea, secondary enterocolitis, eosinophilia, ototoxicity


Overdosage/Toxicology

Symptoms of overdose include nausea, vomiting, diarrhea

Following GI decontamination, if possible; care is supportive and symptomatic


Drug Interactions

Decreased effect of digoxin, vitamin A, and methotrexate

Increased effect of oral anticoagulants, neuromuscular blockers, and polypeptide antibiotics


Mechanism of Action

Acts directly on ameba; has antibacterial activity against normal and pathogenic organisms in the GI tract; interferes with bacterial protein synthesis by binding to 30S ribosomal subunits


Pharmacodynamics/Kinetics

Absorption: Not absorbed via oral route

Elimination: 100% unchanged in feces


Usual Dosage

Oral:

Dientamoeba fragilis: Children and Adults: 25-30 mg/kg/day in 3 divided doses for 7 days

Cryptosporidium: Adults with AIDS: 1.5-2.25 g/day in 3-6 divided doses for 10-14 days (occasionally courses of up to 4-8 weeks may be needed)

Tapeworm (fish, dog, bovine, porcine):

Children: 11 mg/kg every 15 minutes for 4 doses

Adults: 1 g every 15 minutes for 4 doses

Hepatic coma: Adults: 4 g/day in 2-4 divided doses for 5-6 days

Dwarf tapeworm: Children and Adults: 45 mg/kg/dose every day for 5-7 days


Dietary Considerations

Paromomycin may cause malabsorption of xylose, sucrose, and fats


Mental Health: Effects on Mental Status

May cause dizziness


Mental Health: Effects on Psychiatric Treatment

None reported


Dental Health: Local Anesthetic/Vasoconstrictor Precautions

No information available to require special precautions


Dental Health: Effects on Dental Treatment

No effects or complications reported


Patient Information

Take as directed, for full course of therapy. Do not skip doses. Maintain adequate hydration (2-3 L/day of fluids unless instructed to restrict fluid intake) and nutrition. If GI upset occurs, small frequent meals, frequent mouth care, sucking lozenges, or chewing gum may help. Report unresolved or severe nausea or vomiting, dizziness, ringing in ears, or loss of hearing. Pregnancy precautions: Inform prescriber if you are pregnant.


Nursing Implications

Monitor hearing loss before and during therapy


Dosage Forms

Capsule, as sulfate: 250 mg


References

Danziger LH, Kanyok TP, and Novak RM, "Treatment of Cryptosporidial Diarrhea in an AIDS Patient With Paromomycin," Ann Pharmacother, 1993, 27(12):1460-2.

"Drugs for Parasitic Infections," Med Lett Drugs Ther, 1998, 40(1017):1-12.

Liu LX and Weller PF, "Antiparasitic Drugs," N Engl J Med, 1996, 334(18):1178-84.


Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved